SEVERITY OF CIRRHOSIS AND THE RELATIONSHIP OF ALPHA-1-ACID GLYCOPROTEIN CONCENTRATION TO PLASMA-PROTEIN BINDING OF LIDOCAINE

被引:37
作者
BARRY, M
KEELING, PWN
WEIR, D
FEELY, J
机构
[1] ST JAMES HOSP,DEPT PHARMACOL & THERAPEUT,DUBLIN 8,IRELAND
[2] ST JAMES HOSP,TRINITY COLL MED SCH,DEPT CLIN MED,DUBLIN 8,IRELAND
关键词
D O I
10.1038/clpt.1990.41
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The concentration of al-acid glycoprotein, the major determinant of the plasma protein binding of basic drugs, and the extent of lidocaine protein binding was related to the severity of liver disease in 30 cirrhotic patients. In comparison with matched control subjects, α1-acid glycoprotein concentration (77 ± 7 versus 37 ± 3 mg/dl; mean ± SEM; p < 0.01) and lidocaine binding (69% ± 2% versus 35% ± 2%; p < 0.01) was markedly reduced. There was a significant negative correlation (r = 0.78; p < 0.01) between free lidocaine and a,-acid glycoprotein concentration. Furthermore, both were significantly related to the severity of liver disease, as assessed by use of the Child Turcotte classification. © 1990.
引用
收藏
页码:366 / 370
页数:5
相关论文
共 19 条
[1]   DECREASED ALPHA-1-ACID GLYCOPROTEIN IN LIVER-CIRRHOSIS - CONSEQUENCES FOR DRUG PROTEIN-BINDING [J].
BARRE, J ;
HOUIN, G ;
ROSENBAUM, J ;
ZINI, R ;
DHUMEAUX, D ;
TILLEMENT, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) :652-653
[2]   PROTEIN-BINDING AND KINETICS OF DRUGS IN LIVER-DISEASES [J].
BLASCHKE, TF .
CLINICAL PHARMACOKINETICS, 1977, 2 (01) :32-44
[3]  
BORGA O, 1977, CLIN PHARMACOL THER, V22, P539
[4]  
CHIO LF, 1979, CANCER-AM CANCER SOC, V43, P596, DOI 10.1002/1097-0142(197902)43:2<596::AID-CNCR2820430229>3.0.CO
[5]  
2-R
[6]   ALPHA-1-ACID GLYCOPROTEIN CONCENTRATION AND MOLECULAR HETEROGENEITY - RELATIONSHIP TO OXPRENOLOL BINDING IN SERUM FROM HEALTHY-VOLUNTEERS AND PATIENTS WITH LUNG-CARCINOMA OR CIRRHOSIS [J].
FRAEYMAN, NF ;
DELLO, CD ;
BELPAIRE, FM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (06) :733-740
[7]  
KISHNER I, 1982, ANN NY ACAD SCI, V89, P39
[8]  
PAXTON JW, 1983, METHOD FIND EXP CLIN, V5, P635
[9]  
PENDERSEN LE, 1987, BR J CLIN PHARM, V23, P41
[10]  
PIAFSKY KM, 1977, CLIN PHARMACOL THER, V22, P545